Contribution of CYP2D6 to 3,4- methylenedioxymethamphetamine (MDMA) disposition in humans: use of paroxetine as a metabolic inhibitor probe

M Segura, M Farré, S Pichini, AM Peiró, PN Roset, A Ramírez, J Ortuño, R Pacifici, PG Zuccaro, J Segura, la Torre R de

Research output: Contribution to journalArticleResearch

51 Citations (Scopus)
Original languageEnglish
Pages (from-to)649-660
JournalClin Pharmacokinet.
Issue number6
Publication statusPublished - 1 Jan 2005

Cite this